Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

Jean-Yves Reginster; M. C. Nevitt; P. Chen; R. K. Dore; D. P. Kiel; J. R. Zanchetta; E. V. Glass; J. H. Krege

Back

Conference proceeding

Peer reviewed

Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis

Jean-Yves Reginster, M. C. Nevitt, P. Chen, R. K. Dore, D. P. Kiel, J. R. Zanchetta, E. V. Glass and J. H. Krege

Osteoporosis International, 17 (Suppl.1), S5 (2006-03); Sixth European Congress on Clinical and Economic aspects of Osteoporosis and Osteoarthritis, Vienna, Austria [AT], du 15 mars 2006 au 18 mars 2006

03/2006

Abstract

General & internal medicine

Human health sciences

Médecine générale & interne

Public health, health care sciences & services

Santé publique, services médicaux & soins de santé

Sciences de la santé humaine

Metrics

1 Record Views

Details

Title: Reduction in the risk of back pain persists at least 30 months after discontinuation of teriparatide treatment: a meta-analysis
Creators - without role: Jean-Yves Reginster
M. C. Nevitt
P. Chen
R. K. Dore
D. P. Kiel
J. R. Zanchetta
E. V. Glass
J. H. Krege
Conference: Osteoporosis International, 17 (Suppl.1), S5 (2006-03); Sixth European Congress on Clinical and Economic aspects of Osteoporosis and Osteoarthritis, Vienna, Austria [AT], du 15 mars 2006 au 18 mars 2006
Publisher: Springer Science & Business Media B.V
Identifiers: 9952492908331
Academic Unit: King Saud University
Language: English
Resource Type: Conference proceeding